CompletedNCT00211250
Switching from valproic acid to extended-release valproate in bipolarity
About this title
Read the official source — NCT00211250Medication studyAges 18+United States
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- JolietSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateJuly 2005
- Recruitment status
- Completed
- Enrollment listed in the registry
- 20
- Sponsor
- Joliet Center for Clinical Research
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT00211250
- Official title
Show the full official title
An Exploratory Study Comparing Compliance, Tolerability, Efficacy and Adverse Events in Bipolar I and II Patients From Valproic Acid to Depakote ER
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Joliet
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Joliet Center for Clinical Research.
Did this study involve medication?
Yes. The study involved medication, including Valproic Acid and Depakote ER.
Who was this study for?
Listed age limits: from 18 years.
